Top 25 Emerging Leaders - 2023

DasGupta oversees the team supporting the Seattle-based health system’s 340B Drug Pricing Program. After drug manufacturers left the 340B community pharmacy program during the COVID-19 pandemic, she developed multiple strategies to help UW Medicine hospitals recoup lost savings. She is a member of the 340B Health Board of Directors and formerly served as assistant director for compliance and audit at UW Medicine.